Jonathan Beer

Jonathan Beer

Company: Novartis

Job title: Global Precision Medicine Strategic Intelligence Lead


Barriers to Adoption of Liquid Biopsy Use in Today’s Healthcare System 1:00 pm

• Although precision medicine therapies have demonstrated benefit to cancer patients the failure to adopt a biomarker testing routine can result in suboptimal patient care • Identification of key barriers to adoption of diagnostics tests and examples of strategies to overcome these barriers will be discussed with respect to liquid biopsy tests • Intrinsic characteristics…Read more

day: Track 2, Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.